Topaz Biosciences

Website

Topaz Biosciences, Inc.

8 Investors
Biotechnology / Skin Health
Emeryville, CA

Topaz Biosciences, Inc. is a biotechnology company that specializes in developing innovative solutions for skin health, with a strong emphasis on harnessing the potential of the skin microbiome. Established in 2022 and based in Emeryville, California, the company is committed to addressing common skin issues such as eczema and acne through scientifically-backed enzyme technology.

Products & Team

Enzyme Technology for Skin Health

Skin CareSeed

Topaz Biosciences offers a cutting-edge enzyme technology that targets and selectively reduces harmful bacteria on the skin while preserving beneficial strains. This innovative approach is designed to rebalance the skin microbiome, making it particularly effective for individuals suffering from eczema and acne.

Value Proposition

This product effectively addresses skin health issues related to harmful bacteria, providing a balanced microbiome that can lead to healthier skin and improved conditions for eczema and acne.

Pain Points

Current skincare solutions often fail to address the underlying bacterial imbalances that contribute to eczema and acne; Topaz Biosciences provides scientifically validated alternatives.

Selective reduction of harmful bacteriaPreservation of beneficial skin microorganismsClinically proven efficacy for skin conditionsFormulatable into various skincare products
Industry
Biotechnology
Primary business sector
Founded
2025
Year established
Location
Emeryville, CA
Primary headquarters

Funding History

Total Raised:
$1.4M
E

Equity Offering

March 2025
$3.2M
Target
Progress
45%
Raised
$1.4M
Target
$3.2M
#000206260525000001